Metalgial

Metamizole, the active ingredient in Metalgial, is a pyrazolone analgesic presented as an oral formulation for systemic use. It is employed to relieve moderate to severe pain and to reduce fever in adult patients. GNH USA supplies Metalgial as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metalgial, a pyrazolone analgesic, is indicated for conditions that involve pain or elevated body temperature. - Pain: Provides analgesic relief for moderate to severe acute or chronic pain. - Fever: Lowers high body temperature in febrile states. - Postoperative pain: Assists in controlling pain after surgical procedures.

Metalgial may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional episodes after dosing. - Dizziness: transient light‑headedness. - Skin rash: mild erythematous eruptions.

Serious or Rare Side Effects: - Agranulocytosis: severe drop in white blood cells, requiring immediate medical attention. - Severe allergic reactions: including anaphylaxis or Stevens‑Johnson syndrome. - Hepatic dysfunction: abnormal liver enzymes or hepatitis.

When prescribing Metalgial, clinicians should consider several safety aspects. - Renal impairment: monitor kidney function and adjust use if needed. - Hepatic disease: use with caution in patients with liver dysfunction. - History of blood disorders: avoid in individuals with prior agranulocytosis or severe leukopenia. - Concomitant NSAIDs: increased risk of gastrointestinal bleeding. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metalgial can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Methotrexate: can enhance methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroids: additive risk of gastrointestinal irritation. - Diuretics: may affect renal clearance of Metamizole. - Other pyrazolones: additive hematologic toxicity.